Tesamorelin (GHRH Receptor Agonist) – Premium Quality API
CAS Number:218949-48-5
Product Classification:Pharmaceutical Peptide API
Product Overview
Tesamorelin is a 44-peptide synthetic growth hormone-releasing hormone analog with an N-terminal modified trans-3-hexenoyl group. It potently stimulates the secretion of endogenous growth hormone and insulin-like growth factor-1 by selectively activating pituitary GHRH receptors, and has both anti-lipolytic and anabolic effects.
Technical Specifications
Purity (HPLC):≥99.0%
Identity (MS): Confirmed by High-Resolution Mass Spectrometry (HRMS)
Appearance: Lyophilized white to off-white powder
Quality Attributes: Full characterization of Critical Quality Attributes (CQAs), including mass balance, counter-ion (acetate/TFA) content, residual moisture, and organic volatile impurities, conducted under strict GMP-compliant quality controls.
Commercial & Supply Chain Logistics
Scalable Supply: Readily available from gram-scale pilot batches up to kilogram-scale (kg) commercial volumes.
Lead Time: Due to the rigorous multi-stage synthesis and strict quality release testing required for large-scale batches, a 1-month advance booking is required for commercial-scale orders.
Regulatory & Compliance Notice
Disclaimer: This product is an active pharmaceutical ingredient (API) or chemical intermediate intended strictly for laboratory research, formulation development, or further manufacturing use. It is not intended for direct human therapeutic use, clinical applications, or direct consumer distribution. All promotional content, data, and descriptions comply fully with domestic (PRC) and international advertising laws regulating pharmaceutical raw materials.